Match!

Adipocyte Mineralocorticoid Receptor

Published on Jan 1, 2019
路 DOI :10.1016/bs.vh.2018.10.005
Marco Infante2
Estimated H-index: 2
,
Andrea Armani12
Estimated H-index: 12
+ 2 AuthorsMassimiliano Caprio25
Estimated H-index: 25
(OU: Open University)
Sources
Abstract
Abstract Mineralocorticoid receptor (MR) has been recently identified in adipose tissue, where its excessive activation contributes to several metabolic derangements often observed in obesity and metabolic syndrome. Recent findings support the existence of a bidirectional cross-talk between adipose tissue and adrenal glands, contributing to obesity-related hyperaldosteronism and subsequent adipocyte MR excessive activation. In this regard, MR pharmacological blockade has led to prevention of weight gain and metabolic benefits in murine models of genetic or diet-induced obesity. However, there is still a lack of knowledge on the potential metabolic effects of MR antagonists in clinical settings. Hence, larger clinical studies are deemed necessary to clarify the role of MR antagonism in obesity and metabolic syndrome in humans.
  • References (97)
  • Citations (0)
馃摉 Papers frequently viewed together
9 Citations
51 Citations
20 Citations
78% of Scinapse members use related papers. After signing in, all features are FREE.
References97
Newest
Objective. Aldosterone and high-density lipoprotein cholesterol (HDL-C) are involved in many pathophysiological processes that contribute to the development of cardiovascular diseases. Previously, associations between the concentrations of aldosterone and certain components of the lipid metabolism in the peripheral circulation were suggested, but data from the general population is sparse. We therefore aimed to assess the associations between aldosterone and HDL-C, low-density lipoprotein choles...
4 CitationsSource
#1Se Hee Min (SNU: Seoul National University)H-Index: 5
#2Se-Hong Kim (Catholic University of Korea)H-Index: 10
Last. Soo Lim (Seoul National University Bundang Hospital)H-Index: 42
view all 10 authors...
5 CitationsSource
#1Tsutomu WadaH-Index: 28
#2Akari IshikawaH-Index: 1
Last. Toshiyasu SasaokaH-Index: 35
view all 15 authors...
10 CitationsSource
#1Marco InfanteH-Index: 2
#2Andrea ArmaniH-Index: 12
Last. Massimiliano Caprio (OU: Open University)H-Index: 25
view all 5 authors...
10 CitationsSource
#1Arnaud Olivier (French Institute of Health and Medical Research)H-Index: 8
#2Bertram Pitt (UM: University of Michigan)H-Index: 101
Last. Anne PizardH-Index: 14
view all 13 authors...
Aims An excessive production of aldosterone influences outcome in patients with heart failure (HF) and in obese patients. Findings from laboratory studies suggest that chronic aldosterone blockade maybe more beneficial in abdominally obese HF-prone rats. In the current study, we investigated if the clinical response to a mineralocorticoid receptor antagonist in mildly symptomatic HF patients varied by abdominal obesity. Methods and results A total of 2587 NYHA class II, reduced ejection fraction...
29 CitationsSource
#1Arnaud OlivierH-Index: 8
#2Bertram PittH-Index: 2
Last. Anne PizardH-Index: 14
view all 13 authors...
An excessive production of aldosterone influences outcome in patients with heart failure (HF) and in obese patients. Findings from laboratory studies suggest that chronic aldosterone blockade maybe more beneficial in abdominally obese HF-prone rats. In the current study, we investigated if the clinical response to a mineralocorticoid receptor antagonist in mildly symptomatic HF patients varied by abdominal obesity. A total of 2587 NYHA class II, reduced ejection fraction HF (HFrEF) patients enro...
22 CitationsSource
#1Antonio GiordanoH-Index: 24
#2Andrea FrontiniH-Index: 30
Last. Saverio CintiH-Index: 69
view all 3 authors...
Current therapies for obesity have limited efficacy and may be associated with substantial adverse effects. Cinti and colleagues discuss the conversion of white fat to brown, thermogenic fat as a potential strategy to curb obesity. Adipocyte conversion could be particularly important in the visceral compartment, as fat in this region is associated with morbidity but is also particularly prone to transdifferentiation.
76 CitationsSource
#1Caterina MammiH-Index: 18
#2MarzollaH-Index: 1
Last. Massimiliano Caprio (OU: Open University)H-Index: 25
view all 11 authors...
A novel combined glucocorticoid-mineralocorticoid receptor selective modulator markedly prevents weight gain and fat mass expansion in mice fed a high-fat diet
15 CitationsSource
#1Wakako Kawarazaki (UTokyo: University of Tokyo)H-Index: 8
#2Toshiro Fujita (UTokyo: University of Tokyo)H-Index: 93
Abstract Obese subjects often have hypertension and related cardiovascular and renal diseases, and this has become a serious worldwide health problem. In obese subjects, impaired renal-pressure natriuresis causes sodium retention, leading to the development of salt-sensitive hypertension. Physical compression of the kidneys by visceral fat and activation of the sympathetic nervous system, renin-angiotensin systems (RAS), and aldosterone/mineralocorticoid receptor (MR) system are involved in this...
37 CitationsSource
#1Shigehiro Karashima (Kanazawa University)H-Index: 10
#2Takashi Yoneda (Kanazawa University)H-Index: 23
Last. Yoshiyu Takeda (Kanazawa University)H-Index: 29
view all 10 authors...
The mineralocorticoid receptor (MR) is expressed in the kidneys and in adipose tissue, and primary aldosteronism (PA) is associated with metabolic syndrome. This study assessed the effects of MR blockade by eplerenone (EPL) and spironolactone (SPL) on blood pressure (BP) and metabolic factors in patients with PA. Fifty-four patients with PA were treated with one of two MRAs, EPL (25-100 mg daily, n=27) or SPL (12.5-100 mg daily, n=27) for 12 months. Visceral (VAT) and subcutaneous adipose tissue...
17 CitationsSource
Cited By0
Newest